NCT05624697

Brief Summary

10 Patients having horizontally deficient anterior maxillary areas will be recruited and a preoperative CBCT will be done. The plan is to graft the defective ridges with simultaneously placing dental implants using a PEEK shell that will be specifically designed, constructed and 3D printed to act as a surgical guide for osteotomy drilling and implant placement as well as housing both the implant and the sticky bone (using a mixture of autogenous bone harvested from the symphysis area and xenograft both mixed with plasmatic matrix); that will be added to augment the defective ridge; the PEEK shell will also act as a barrier membrane for Guided Bone Regeneration and will add more stability to the placed implants that will be fixed to the PEEK shell occlusally with a Ti - based abutment. Primary stability will be measured using Ostell and an immediate postoperative CBCT will be done and superimposed on the preoperative CBCT and an accuracy of plan transfer will be measured to make sure the planning was followed accurately. Then 6 months later, another CBCT will be done to check the bone gain and quality and a second surgery will be done to remove the PEEK shell and proceed with the conventional implant prosthetic phase.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 13, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

November 22, 2022

Completed
3 days until next milestone

Study Start

First participant enrolled

November 25, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 25, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 25, 2024

Completed
Last Updated

November 22, 2022

Status Verified

November 1, 2022

Enrollment Period

1 year

First QC Date

November 13, 2022

Last Update Submit

November 18, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Bone gain

    Serial CBCT images (T0 before surgery, T1 immediately after surgery and T2 after 6 months) measuring bone gain in mm

    T0 before surgery, T1 immediately after surgery and T2 after 6 months

Secondary Outcomes (3)

  • Clinically successful osseointegrated implant

    At the day of the surgery and 6 months after first surgery

  • Accuracy of Plan Transfer

    1-3 days postoperatively

  • Bone Quality

    0 before surgery, T1 immediately after surgery and T2 after 6 months

Study Arms (1)

Augmented group

OTHER

Patient Specific Sticky Bone /Implant Housing PEEK Shell in Anterior Atrophic Maxilla with simultaneous implant placement

Procedure: sticky bone housed in PEEK Shell

Interventions

Patient specific Sticky Bone/Implant housing PEEK shell in Anterior Atrophic Maxilla

Augmented group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients with Multiple missing Maxillary Anterior Teeth with horizontally defective ridges having adequate soft tissue ample.
  • Patients who already gave their consent for this trial.
  • Males and females both will be included.

You may not qualify if:

  • Patients on bisphosphonates or drugs altering bone metabolism, within 2 months before initiating the study.
  • Subjected to irradiation in the head and neck region within the last year
  • Patients allergic to drugs used in the study like ( Articaine, Lidocaine,
  • Patients having a history of a major medical condition (ASA 3,4)
  • Untreated periodontitis.
  • Poor oral hygiene and motivation.
  • Uncontrolled diabetes.
  • Pregnant or nursing.
  • Substance abuse.
  • Psychiatric problems or unrealistic expectations.
  • Severe bruxism or clenching.
  • Immunosuppressed or immunocompromised.
  • Treated or under treatment with intravenous amino-bisphosphonates.
  • Active infection or severe inflammation in the area intended for implant placement.
  • Unable to open mouth sufficiently to accommodate the surgical tooling.
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry, Cairo University

Cairo, 11553, Egypt

RECRUITING

Central Study Contacts

Mohamed MS Bahgat, BDS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 13, 2022

First Posted

November 22, 2022

Study Start

November 25, 2022

Primary Completion

November 25, 2023

Study Completion

May 25, 2024

Last Updated

November 22, 2022

Record last verified: 2022-11

Locations